Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 49.60K CHF in the quarter ending September 30, 2025, a decrease of -14.99%. This brings the company's revenue in the last twelve months to 158.54K, down -73.24% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.

• Revenue (ttm): 158.54K
• Revenue Growth: -73.24%
• P/S Ratio: 29.41
• Revenue / Employee: 79.27K
• Employees: 2
• Market Cap: 4.66M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	410.04K	-1.21M	-74.64%
Dec 31, 2023	1.62M	172.23K	11.92%
Dec 31, 2022	1.44M	-1.71M	-54.18%
Dec 31, 2021	3.15M	-725.84K	-18.71%
Dec 31, 2020	3.88M	1.05M	36.89%
Dec 31, 2019	2.83M	-3.87M	-57.72%
Dec 31, 2018	6.70M	6.20M	1,240.82%
Dec 31, 2017	499.89K	373.24K	294.70%
Dec 31, 2016	126.65K	-348.97K	-73.37%
Dec 31, 2015	475.63K	-	-